Investor Update
Basel, 20 June 2006
Invitation
to conference call on Roche data and results at EULAR 2006
Friday,
June 23, 2006
We kindly invite you to participate in an analyst
and investor
conference call to present and discuss new data and results presented during the 2006 EULAR conference
(The European League Against Rheumatism) on June 21-23 in Amsterdam, The Netherlands. The conference
call will take place:
Friday, June 23, 2006 from 14:30 to 15:30 CET /
08:30 to 09:30 EST
Participants will be:
Dr.
Karl Mahler, Head of Investor Relations, Roche
Dr. Urs Schleuniger,
Business Director,
Hematology & Autoimmune Diseases, Roche
Prof. Paul Emery, arc
Professor of Rheumatology,
Head of Musculoskeletal Unit, University of Leeds, UK
Prof. Edward C Keystone,
Professor
of Medicine, University of Toronto, Canada
Analysts
and investors are invited to dial in to the conference call using the following dial-in numbers:
+41
(0) 91 610 56 00 (Europe and ROW)
+44 (0) 207 107 06 11 (UK )
+1 (1)
866 291 41 66 (USA Toll Free)
Please dial in to the
conference call 10 – 15 minutes before the call is scheduled to start.
Alternatively,
a live audio webcast can be accessed via http://ir.roche.com.
Ahead
of the call, the presentation will be available from the IR website at http://ir.roche.com.
A replay of the conference call will be available one hour after the conference call,
for 48 hours.
Access is by dialling:
+41
(0) 91 612 43 30 (Europe and ROW)
+44 (0) 207 108 62 33 (UK )
+1
(1) 866 416 25 58 (USA)
Listeners will be asked to
enter the ID 487 followed by the # sign.